Article
Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge
15 Apr 2022
Abstract excerpt
Humans have four IgG antibody subclasses that selectively or differentially engage immune effector molecules to protect against infections. Although IgG1 has been studied in detail and is the subclass of most approved antibody therapeutics, increasing evidence indicates that IgG3 is associated with enhanced protection against pathogens. Here, we report that IgG3 has superior capacity to mediate intracellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
